Hepatitis C Virus Therapy
Anti-hepatitis C virus effects of interferon and ribavirin detected
Published in Hepatitis Weekly, January 9th, 2006
"Although combination therapy with interferon and ribavirin has improved the treatment for chronic HCV infection, the detailed anti-HCV effect of ribavirin in clinical concentrations remains uncertain," wrote T. Kato and colleagues, Tokyo Metropolitan Institute of Neuroscience.
"To detect the anti-HCV effect of ribavirin in lower concentrations, a sensitive and accurate assay system was developed using the reporter replicon system with an HCV genotype 2a subgenomic replicon (clone JFH-1) that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-01-09)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Extraction of hepatitis B virus RNA and DNA automated for real-time PCR - Hepatitis B Virus
HBV DNA detected in saliva, urine and serum of chronic hepatitis B patients - Hepatitis B Virus
HBV replication is suppressed independent of core protein phosphorylation - Hepatitis C Virus
Chronic viral hepatitis influences graft survival in renal transplant patients - Apoptosis
Researchers report details of new studies and findings in the area of apoptosis - Autoimmune Diseases
Cytotoxic antigen induces autoimmune hypophysitis in cancer patients - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
